Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 581 entries
View as:

Immunological Function After Radiation With Either Proton or Photon Therapy

Phase: N/A Priority: Normal
NCT ID: NCT06016699 Org: User:
Start: 09/23/21 End: 04/01/24 Due: 04/01/25

Anti-COVID19 AKS-452 Fusion Protein Vaccine - ACT Study

Phase: N/A Priority: Normal
NCT ID: NCT04681092 Org: User:
Start: 04/06/21 End: 03/10/22 Due: 03/10/23

TransplantLines Food and Nutrition Biobank and Cohort Study (TxL-FN)

Phase: N/A Priority: Normal
NCT ID: NCT02811835 Org: User:
Start: 11/30/08 End: 11/30/28 Due: 11/30/29

[18F]MC225-PET in Neurodegenerative Disease

Phase: N/A Priority: Normal
NCT ID: NCT05853471 Org: User:
Start: 02/01/22 End: 01/01/24 Due: 01/01/25

Method VALIDation and Evaluation of Non-radioactive Methods to Measure Glomerular Filtration Rate

Phase: N/A Priority: Normal
NCT ID: NCT06259422 Org: User:
Start: 06/01/24 End: 09/01/25 Due: 09/01/26

Microbiome Composition Changes on 4 Week Gluten-free Diet Challenge

Phase: N/A Priority: Normal
NCT ID: NCT02731976 Org: User:
Start: 11/30/11 End: 05/31/14 Due: 05/31/15

Ablation in Patients With HF and Symptomatic AF: PULVERISE-AF-CRT

Phase: N/A Priority: Normal
NCT ID: NCT05760833 Org: User:
Start: 12/01/22 End: 04/08/24 Due: 04/08/25

Identification of Predictive Parameters for Colitis in Melanoma Patients Treated With Immunotherapy.

Phase: N/A Priority: Normal
NCT ID: NCT02600143 Org: User:
Start: 08/31/13 End: 04/30/19 Due: 04/30/20

Reappraisal of Atrial Fibrillation: Interaction Between HyperCoagulability, Electrical Remodeling, and Vascular Destabilisation in the Progression of Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT02726698 Org: User:
Start: 07/31/16 End: 10/31/24 Due: 10/31/25

Electroencephalogram Based Real-Time Sedation Level Prediction

Phase: N/A Priority: Normal
NCT ID: NCT05757622 Org: User:
Start: 03/01/23 End: 04/01/25 Due: 04/01/26

Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA)

Phase: N/A Priority: Normal
NCT ID: NCT00103792 Org: User:
Start: 12/31/04 End: 01/31/15 Due: 01/31/16

68Ga-FAPI PET/CT to Detect Ongoing Fibroblast Activity in Post-acute COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT05981885 Org: User:
Start: 06/09/22 End: 05/17/24 Due: 05/17/25

APPEndicitis and Laparoscopic Criteria; APPEL Study

Phase: N/A Priority: Normal
NCT ID: NCT01054417 Org: User:
Start: 12/31/09 End: 07/31/11 Due: 07/31/12

Spirometry in Esophageal Intubation

Phase: N/A Priority: Normal
NCT ID: NCT01080508 Org: User:
Start: 12/31/09 End: 08/31/10 Due: 08/31/11

Oxidative Skeletal Muscle Metabolism in Chronic Heart Failure Patients With and Without Iron Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT05750940 Org: User:
Start: 10/05/21 End: 05/01/23 Due: 05/01/24

Corticosteroids as Additive in Temporomandibular Joint (TMJ) Arthrocentesis

Phase: N/A Priority: Normal
NCT ID: NCT01275014 Org: User:
Start: 12/31/08 End: 12/31/10 Due: 12/31/11

Simple Intensive Care Studies I (SICS-I)

Phase: N/A Priority: Normal
NCT ID: NCT02912624 Org: User:
Start: 03/27/15 End: 11/01/17 Due: 11/01/18

Targeted Fluorescence Imaging in AMD

Phase: N/A Priority: Normal
NCT ID: NCT05262244 Org: User:
Start: 10/28/22 End: 03/30/24 Due: 03/30/25

Side Effects of Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor Receptor (EGFR) Directed Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00657098 Org: User:
Start: 03/31/08 End: 10/31/15 Due: 10/31/16

Visualization of Rectal Cancer During Endoscopy, Using a Fluorescent Tracer

Phase: N/A Priority: Normal
NCT ID: NCT01972373 Org: User:
Start: 10/31/13 End: 01/31/17 Due: 01/31/18

Fluorescence Imaging of IBD and RA Using Adalimumab-800CW

Phase: N/A Priority: Normal
NCT ID: NCT03938701 Org: User:
Start: 06/30/23 End: 12/31/24 Due: 12/31/25

Paracrine Mechanisms of Bone Marrow Stem Cell Signalling in Chronic Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT01086787 Org: User:
Start: 08/31/10 End: 12/31/11 Due: 12/31/12

Neo-adjuvant Pembrolizumab as an Alternative Treatment for MMRd Uterine Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06180733 Org: User:
Start: 12/01/23 End: 01/31/28 Due: 01/31/29

HRZE Fasted/Fed in Newly Diagnosed TB

Phase: N/A Priority: Normal
NCT ID: NCT02121314 Org: User:
Start: 07/31/13 End: 06/30/14 Due: 06/30/15

Pharmacokinetics of Micafungin in Critically Ill Patients

Phase: N/A Priority: Normal
NCT ID: NCT01716988 Org: User:
Start: 10/31/12 End: 01/31/17 Due: 01/31/18